Contrasting United American Healthcare (OTCMKTS:UAHC) and iCAD (NASDAQ:ICAD)

iCAD (NASDAQ:ICAD) and United American Healthcare (OTCMKTS:UAHC) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for iCAD and United American Healthcare, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iCAD	0	3	0	0	2.00
United American Healthcare	0	0	0	0	0.00

Earnings & Valuation

This table compares iCAD and United American Healthcare”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iCAD	$19.53 million	5.18	-$4.85 million	($0.19)	-19.37
United American Healthcare	N/A	N/A	$720,000.00	N/A	N/A

United American Healthcare has lower revenue, but higher earnings than iCAD.

Profitability

This table compares iCAD and United American Healthcare’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
iCAD	-17.81%	-15.65%	-12.52%
United American Healthcare	N/A	N/A	N/A

Insider & Institutional Ownership

24.6% of iCAD shares are held by institutional investors. 10.3% of iCAD shares are held by company insiders. Comparatively, 14.3% of United American Healthcare shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Risk & Volatility

iCAD has a beta of 1.38, suggesting that its stock price is 38% more volatile than the S&P 500. Comparatively, United American Healthcare has a beta of -1.54, suggesting that its stock price is 254% less volatile than the S&P 500.

Summary

United American Healthcare beats iCAD on 5 of the 9 factors compared between the two stocks.

About iCAD

iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

About United American Healthcare

United American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois.